Liposarcoma - 29 Studies Found
| Active, not recruiting |
: Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial : Advanced and / or Metastatic Liposarcoma : 2012-09-14 : Drug: Pazopanib Patients will receive oral pazopanib, 800mg once daily and treatment will continue until |
| Recruiting |
: A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma :
|
| Completed |
: PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma :
: 2010-09-24 : Drug: Palbociclib Treatment will consist of either: |
| Recruiting |
: Study of Abemaciclib in Dedifferentiated Liposarcoma :
: 2016-07-25 : Drug: Abemaciclib Other Name: LY2835219 |
| Active, not recruiting |
: A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma :
: 2015-10-06 : Drug: ribociclib Oral, 600 mg x 1 a day, duration - according to response |
| Completed |
: A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma :
: Drug: oral 5-azacitidine in combination with romidepsin DO |
| Completed |
: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma :
|
| Completed |
: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas :
|
| Completed |
: Phase I-II Trial, Multicenter, Open, Exploring Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients :
: 2014-10-17 :
|